News Detail
London, 7 Feb 2024: New research has identified why some advanced oestrogen receptor (ER) positive breast cancers become resistant to hormone therapy, and has identified drugs currently in development that could keep disease stable for longer for these patients.
Source : Institute of Cancer Research
advanced oestrogen receptor (ER)
positive breast cancers
resistant to hormone therapy
Institute of Cancer Research
oestrogen receptor gene (ESR1) called F404
Related News
- Mandimycin: A polyene antifungal with a unique mode of action (22-03-2025)
- Newly identified bacterial protein helps design cancer drug delivery system (21-03-2025)
- IIT Roorkee researchers identify a potential drug against Chikungunya (18-03-2025)
- New test enables doctors to anticipate a serious side effect of cancer therapy (17-03-2025)
- Chinese vaccine shows promise in stopping plaque build-up in arteries (15-03-2025)
- Researchers develop technique for storing life-saving drugs without temperature control (15-03-2025)
- NIT researchers develop eco-friendly process to remove pharmaceutical pollutants from wastewater (14-03-2025)
- New personalised vaccine shows promise in treating deadly pancreatic cancer (13-03-2025)
- Human body's protein recycling system fights bacteria like antibiotics: Study (06-03-2025)
- Researchers at IIT Kanpur Identify Crucial Drug Target Receptor for Treating Cancer and Respiratory Diseases (22-02-2025)